Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1119]
News [2438]
Articles [146]
Editorials [8]
Conferences [102]
elearning [12]
Utilising disease heterogeneity and emerging biomarkers to individualise...
Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Utilising disease heterogeneity and emerging biomarkers to individualise prostate treatment ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
22 Jan 2016
The ManVan: a mobile cancer support service for men with prostate, testicular...
Dr Rachel Iredale -Tenovus Cancer Care, Cardiff, Wales, UK and University of...
The ManVan: a mobile cancer support service for men with prostate, testicular and penile cancer in Wales ( Dr Rachel Iredale -Tenovus Cancer Care, Cardiff, Wales, UK and University of South Wales, Pontypridd, Wales, UK )
11 Jan 2016
Entinostat and high-dose Interleukin 2 in renal cell carcinoma patients
Prof Roberto Pili - Indiana University, Indianapolis, USA
Entinostat and high-dose Interleukin 2 in renal cell carcinoma patients ( Prof Roberto Pili - Indiana University, Indianapolis, USA )
9 Jan 2016
Best of ASCO GU 2016 prostate cancer data
Prof Noel Clarke, Dr Heather Payne, Prof Peter Iverson
Best of ASCO GU 2016 prostate cancer data ( Prof Noel Clarke, Dr Heather Payne, Prof Peter Iverson )
8 Jan 2016
Gemcitabine plus cisplatin plus ipilimumab for metastatic urothelial cancer
Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA
Gemcitabine plus cisplatin plus ipilimumab for metastatic urothelial cancer ( Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA )
8 Jan 2016
Avelumab for metastatic urothelial carcinoma: JAVELIN trial
Dr Andrea Apolo - National Cancer Institute, Maryland, USA
Avelumab for metastatic urothelial carcinoma: JAVELIN trial ( Dr Andrea Apolo - National Cancer Institute, Maryland, USA )
8 Jan 2016
Subgroup analyses of METEOR; randomized phase III trial of cabozantinib vs...
Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
Subgroup analyses of METEOR; randomized phase III trial of cabozantinib vs everolimus for RCC ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
8 Jan 2016
Integrated genomic correlates of response to PD-1 inhibitor nivolumab in mRCC
Dr Guillermo de Velasco - Dana-Farber Cancer Institute, Boston, USA
Integrated genomic correlates of response to PD-1 inhibitor nivolumab in mRCC ( Dr Guillermo de Velasco - Dana-Farber Cancer Institute, Boston, USA )
8 Jan 2016
Discontinuing VEGF-targeted therapy for progression or toxicity affects...
Dr Guillermo de Velasco - Dana-Farber Cancer Institute, Boston, USA
Discontinuing VEGF-targeted therapy for progression or toxicity affects outcomes of second-line therapies in mRCC ( Dr Guillermo de Velasco - Dana-Farber Cancer Institute, Boston, USA )
8 Jan 2016
Impact of metformin on outcomes for metastatic renal cell carcinoma
Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA
Impact of metformin on outcomes for metastatic renal cell carcinoma ( Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA )
8 Jan 2016
Comparing adjuvant radiotherapy plus chemo vs. adjuvant chemo following...
Dr Brian Baumann - University of Pennsylvania, Philadelphia, USA
Comparing adjuvant radiotherapy plus chemo vs. adjuvant chemo following cystectomy for bladder cancer ( Dr Brian Baumann - University of Pennsylvania, Philadelphia, USA )
8 Jan 2016
Molecular genetics of testicular cancer: What does the clinician need to know?
Dr Katherine Nathanson - University of Pennsylvania, Philadelphia, USA
Molecular genetics of testicular cancer: What does the clinician need to know? ( Dr Katherine Nathanson - University of Pennsylvania, Philadelphia, USA )
8 Jan 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation